Holen Sie sich die Stockscreener-App
4.16
4.26%
0.17
Handel nachbörslich:
4.11
-0.05
-1.20%
Schlusskurs vom Vortag:
$3.99
Offen:
$3.985
24-Stunden-Volumen:
7.18M
Relative Volume:
1.15
Marktkapitalisierung:
$1.24B
Einnahmen:
$38.03M
Nettoeinkommen (Verlust:
$-146.40M
KGV:
-8.00
EPS:
-0.52
Netto-Cashflow:
$-121.38M
1W Leistung:
-3.26%
1M Leistung:
-4.15%
6M Leistung:
+77.78%
1J Leistung:
+65.08%
1-Tages-Spanne:
$3.83
$4.175
1-Wochen-Bereich:
$3.83
$4.40
52-Wochen-Spanne:
$1.8906
$5.82
Abcellera Biologics Inc Stock (ABCL) Company Profile
Firmenname
Abcellera Biologics Inc
Sektor
Branche
Telefon
(604) 559-9005
Adresse
150 W 4TH AVENUE, VANCOUVER
Vergleichen Sie ABCL mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ABCL
Abcellera Biologics Inc
|
4.16 | 1.21B | 38.03M | -146.40M | -121.38M | -0.52 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Abcellera Biologics Inc Stock (ABCL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-07 | Fortgesetzt | Leerink Partners | Outperform |
| 2024-08-20 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2024-02-22 | Hochstufung | The Benchmark Company | Hold → Buy |
| 2023-12-05 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2023-11-06 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2023-10-13 | Fortgesetzt | Piper Sandler | Overweight |
| 2023-02-28 | Eingeleitet | Cowen | Outperform |
| 2022-12-15 | Eingeleitet | Goldman | Buy |
| 2022-11-16 | Eingeleitet | Truist | Buy |
| 2021-12-21 | Eingeleitet | The Benchmark Company | Buy |
| 2021-11-19 | Eingeleitet | Piper Sandler | Overweight |
| 2021-01-05 | Eingeleitet | BMO Capital Markets | Outperform |
| 2021-01-05 | Eingeleitet | Berenberg | Buy |
| 2021-01-05 | Eingeleitet | Credit Suisse | Outperform |
| 2021-01-05 | Eingeleitet | SVB Leerink | Outperform |
| 2021-01-05 | Eingeleitet | Stifel | Buy |
Alle ansehen
Abcellera Biologics Inc Aktie (ABCL) Neueste Nachrichten
Trend analysis for AbCellera Biologics Inc. this weekJuly 2025 Closing Moves & Safe Capital Growth Stock Tips - Newser
Analyzing drawdowns of AbCellera Biologics Inc. with statistical toolsRisk Management & Reliable Volume Spike Trade Alerts - Newser
Applying Elliott Wave Theory to AbCellera Biologics Inc.July 2025 Rallies & Verified Entry Point Detection - Newser
What the charts say about AbCellera Biologics Inc. today2025 Price Momentum & Consistent Growth Stock Picks - Newser
Applying big data sentiment scoring on AbCellera Biologics Inc.Product Launch & Fast Momentum Entry Tips - Newser
Can machine learning forecast AbCellera Biologics Inc. recoveryJuly 2025 Chart Watch & Low Drawdown Momentum Trade Ideas - Newser
AbCellera Biologics Inc.’s volatility index tracking explainedAnalyst Downgrade & Free High Return Stock Watch Alerts - Newser
Is AbCellera Biologics Inc. stock reversal real or fakeStock Surge & Safe Swing Trade Setup Alerts - Newser
Can a trend reversal in AbCellera Biologics Inc. lead to recoveryEntry Point & Risk Managed Investment Signals - Newser
Has AbCellera Biologics Inc. formed a bullish divergenceMarket Growth Review & Step-by-Step Trade Execution Guides - Newser
Chart based analysis of AbCellera Biologics Inc. trendsWeekly Gains Report & Community Consensus Trade Alerts - Newser
What indicators show strength in AbCellera Biologics Inc.Trade Performance Summary & AI Optimized Trade Strategies - Newser
Identifying reversal signals in AbCellera Biologics Inc.Weekly Risk Report & Fast Exit Strategy with Risk Control - Newser
Will AbCellera Biologics Inc. outperform the marketWeekly Trade Review & AI Driven Price Predictions - Newser
Is AbCellera Biologics Inc. affected by consumer sentiment2025 Major Catalysts & Verified Momentum Watchlists - khodrobank.com
Does AbCellera Biologics Inc. have consistent dividend growthWeekly Loss Report & Fast Momentum Stock Entry Tips - khodrobank.com
Is AbCellera Biologics Inc. part of any ETFProduct Launch & AI Based Buy and Sell Signals - khodrobank.com
How does AbCellera Biologics Inc. score in quality rankingsJuly 2025 Snapshot & Weekly Top Gainers Trade List - خودرو بانک
Published on: 2025-09-02 15:57:51 - Newser
Is AbCellera Biologics Inc. a momentum stockTrade Risk Report & Fast Entry and Exit Trade Plans - khodrobank.com
Real time scanner hits for AbCellera Biologics Inc. explainedIndex Update & Risk Controlled Swing Trade Alerts - Newser
Opinion: Defence spending must include health spending too - The Globe and Mail
Evaluating AbCellera Biologics Inc. with trendline analysis2025 Technical Patterns & Low Drawdown Investment Ideas - Newser
Applying chart zones and confluence areas to AbCellera Biologics Inc.Weekly Market Outlook & Intraday High Probability Setup Alerts - Newser
Smart tools for monitoring AbCellera Biologics Inc.’s price actionWeekly Trade Recap & Fast Moving Market Watchlists - Newser
How to recover losses in AbCellera Biologics Inc. stockJuly 2025 Reactions & Short-Term High Return Strategies - Newser
Is AbCellera Biologics Inc. on track to beat earnings2025 Growth vs Value & Short-Term Trading Alerts - khodrobank.com
MACD Cross Could Confirm Trend in AbCellera Biologics Inc. getLinesFromResByArray error: size == 0 - kangso.co.kr
AbCellera Biologics Inc. stock trend outlook and recovery path2025 Top Gainers & Risk Controlled Daily Trade Plans - Newser
Volume spikes in AbCellera Biologics Inc. stock – what they meanWeekly Profit Analysis & Smart Allocation Stock Reports - Newser
Detecting price anomalies in AbCellera Biologics Inc. with AIMarket Movement Recap & Technical Entry and Exit Tips - Newser
Can Traders Expect Breakout From AbCellera Biologics Inc. This Week getLinesFromResByArray error: size == 0 - kangso.co.kr
Can AbCellera Biologics Inc. keep up with sector leaders2025 Price Targets & Smart Investment Allocation Tips - khodrobank.com
Can Traders Expect Breakout From AbCellera Biologics Inc. This WeekMarket Movers & Reliable Price Action Trade Plans - beatles.ru
Truist Financial Reiterates a Buy Rating on AbCellera Biologics (ABCL), Sets a $10 PT - MSN
How to build a dashboard for AbCellera Biologics Inc. stockWeekly Trend Recap & Community Verified Swing Trade Signals - Newser
Momentum divergence signals in AbCellera Biologics Inc. chart2025 Price Action Summary & Low Risk Entry Point Tips - Newser
Chart overlay techniques for tracking AbCellera Biologics Inc.2025 Year in Review & Reliable Entry Point Trade Alerts - Newser
Finanzdaten der Abcellera Biologics Inc-Aktie (ABCL)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.75%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):